EPO Patents = 3

Trademarks = 4

Forward Citations = 19

Loading Chart...

12 inventors (with patents filed for the assignee):

Peter Ordentlich (5 out of 6 patents)

Robert Goodenow (2 out of 8 patents)

Lei Wang (2 out of 2 patents)

4. William Henry Miller (1 out of 73 patents)

5. Salvacion Cacatian (1 out of 33 patents)

6. Santosh Shripad Kulkarni (1 out of 52 patents)

7. Gerard M Mcgeehan (1 out of 1 patent)

8. Nicholas Paul Camp (1 out of 1 patent)

9. Swapan Kumar Samanta (1 out of 1 patent)

10. Virsinha Venkat Reddy (1 out of 1 patent)

11. Serap Sankoh (1 out of 1 patent)

12. Michael Meyers (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12168054 - Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody (2024-12-17),

2. 12000829 - Selection of patients for combination therapy (2024-06-04),

3. 11919901 - Inhibitors of the menin-MLL interaction (2024-03-05),

4. 11397184 - Selection of patients for combination therapy (2022-07-26),

5. 11324822 - Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer (2022-05-10),

6. 10226472 - Methods for the treatment of breast cancer (2019-03-12),

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer. The company's lead product candidate, entinostat, is being investigated in multiple combination trials for various cancer types. Syndax is committed to delivering innovative treatment options to patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#152 in Waltham, MA

#2,473 in Massachusetts

#43,798 in US

Waltham, MA, United States of America

Syndax Pharmaceuticals, Inc.